Helios Digital Ventures

Wole Coaxum, the firm's Founder and Managing Partner, leads all investment decisions. Prior to launching Helios Digital Ventures in 2020, he served as Managing Director at JPMorgan Chase, where he built the firm's minority depository institution program. His background spans institutional financial services and workforce-benefits advisory at Willis Towers Watson.

Helios Digital Ventures focuses on seed and Series A rounds. The firm writes first-check or early-stage checks, often as the institutional lead or co-lead alongside aligned venture partners. Its capital is deployed with a view toward long-term company building rather than passive index-style exposure.

The firm draws heavily on Wole Coaxum's network across the banking, payments, and institutional asset-management sectors. Because Helios Digital Ventures targets startups selling into regulated financial institutions and workforce-benefits ecosystems, Coaxum's relationships with decision-makers at large banks and insurers surface opportunities that generalist firms may not see.

The firm has not publicly listed negative sector screens, but its thesis concentrates on FinTech, enterprise software, digital health, and the future of work. Capital-intensive sectors such as deep tech hardware, clean energy infrastructure, and biopharma are outside its observed deal pattern.

Helios Digital Ventures operates as a traditional venture capital firm, not a family office. It raises institutional and LP capital through a fund structure. Coaxum's institutional background at JPMorgan Chase shapes the firm's discipline and compliance posture, but its capital comes from external limited partners.

There is no public evidence of a related philanthropic foundation tied directly to Helios Digital Ventures. The firm's investment thesis includes economic inclusion as a strategic priority, but that focus is executed through for-profit venture investing rather than grant-making or a separate 501(c)(3) entity.

The firm has not published a formal co-investment policy. In practice, its early-stage focus suggests it frequently participates in rounds alongside other seed and Series A funds. Coaxum's institutional relationships likely position the firm as a syndicate partner for GPs seeking a connection to regulated financial buyers.